x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
Large accelerated filer
x
|
|
Accelerated filer
o
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
Item
|
|
|
Page
|
|
|
Part I
—
Financial Information
|
|
1.
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
2.
|
|
||
3.
|
|
||
4.
|
|
||
|
|
Part II
—
Other Information
|
|
1.
|
|
||
1A.
|
|
||
2.
|
|
||
6.
|
|
||
|
|
Part I.
|
Financial Information
|
Item 1.
|
Financial Statements
|
|
Three Months Ended
|
||||||
|
March 28, 2015
|
|
March 31, 2014
|
||||
Net Sales
|
$
|
221,348
|
|
|
$
|
243,499
|
|
Cost of Sales
|
184,476
|
|
|
188,719
|
|
||
Gross Margin
|
36,872
|
|
|
54,780
|
|
||
|
|
|
|
||||
Selling and general expenses
|
12,296
|
|
|
8,226
|
|
||
Other operating expense, net (Note 8)
|
630
|
|
|
3,190
|
|
||
Operating Income
|
23,946
|
|
|
43,364
|
|
||
Interest expense
|
9,324
|
|
|
—
|
|
||
Interest and miscellaneous income, net
|
(29
|
)
|
|
—
|
|
||
Income Before Income Taxes
|
14,651
|
|
|
43,364
|
|
||
Income tax expense (Note 9)
|
4,130
|
|
|
12,417
|
|
||
Net Income
|
$
|
10,521
|
|
|
$
|
30,947
|
|
|
|
|
|
||||
Earnings Per Share of Common Stock (Note 7)
|
|
|
|
||||
Basic earnings per share
|
$
|
0.25
|
|
|
$
|
0.73
|
|
Diluted earnings per share
|
$
|
0.25
|
|
|
$
|
0.73
|
|
|
|
|
|
||||
Dividends Declared Per Share
|
$
|
0.07
|
|
|
$
|
—
|
|
Comprehensive Income:
|
|
|
|
||||
Net Income
|
$
|
10,521
|
|
|
$
|
30,947
|
|
Other Comprehensive Income
|
|
|
|
||||
Net gain from pension and postretirement plans, net of income tax expense of $1,299 and $477
|
2,308
|
|
|
830
|
|
||
Total other comprehensive income
|
2,308
|
|
|
830
|
|
||
Comprehensive Income
|
$
|
12,829
|
|
|
$
|
31,777
|
|
|
March 28, 2015
|
|
December 31, 2014
|
||||
Assets
|
|||||||
Current Assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
77,621
|
|
|
$
|
65,977
|
|
Accounts receivable, less allowance for doubtful accounts of $151 and $151
|
51,688
|
|
|
69,263
|
|
||
Inventory (Note 2)
|
131,937
|
|
|
140,209
|
|
||
Deferred tax assets
|
8,534
|
|
|
8,275
|
|
||
Prepaid and other current assets
|
31,936
|
|
|
36,267
|
|
||
Total current assets
|
301,716
|
|
|
319,991
|
|
||
Property, Plant and Equipment, Gross
|
2,026,725
|
|
|
2,010,644
|
|
||
Less — Accumulated Depreciation
|
(1,186,162
|
)
|
|
(1,167,269
|
)
|
||
Property, Plant and Equipment, Net
|
840,563
|
|
|
843,375
|
|
||
Deferred Tax Assets
|
78,666
|
|
|
78,547
|
|
||
Other Assets
|
60,905
|
|
|
61,967
|
|
||
Total Assets
|
$
|
1,281,850
|
|
|
$
|
1,303,880
|
|
Liabilities and Stockholders’ Deficit
|
|||||||
Current Liabilities
|
|
|
|
||||
Accounts payable
|
$
|
55,243
|
|
|
$
|
64,697
|
|
Current maturities of long-term debt (Note 3)
|
8,207
|
|
|
8,400
|
|
||
Accrued income and other taxes
|
5,551
|
|
|
4,643
|
|
||
Accrued payroll and benefits
|
14,171
|
|
|
23,124
|
|
||
Accrued interest
|
10,228
|
|
|
2,684
|
|
||
Accrued customer incentives
|
9,169
|
|
|
12,743
|
|
||
Accrued professional services
|
1,875
|
|
|
755
|
|
||
Other current liabilities
|
6,793
|
|
|
7,158
|
|
||
Dividends payable
|
2,953
|
|
|
—
|
|
||
Current liabilities for disposed operations (Note 5)
|
8,366
|
|
|
7,241
|
|
||
Total current liabilities
|
122,556
|
|
|
131,445
|
|
||
Long-Term Debt (Note 3)
|
916,675
|
|
|
936,416
|
|
||
Non-Current Liabilities for Disposed Operations (Note 5)
|
147,365
|
|
|
149,488
|
|
||
Pension and Other Postretirement Benefits (Note 11)
|
140,450
|
|
|
141,338
|
|
||
Other Non-Current Liabilities
|
7,392
|
|
|
7,605
|
|
||
Commitments and Contingencies
|
|
|
|
||||
Stockholders’ Deficit
|
|
|
|
||||
Preferred stock, 10,000,000 shares authorized at $0.01 par value, 0 issued and outstanding as of March 28, 2015 and December 31, 2014
|
—
|
|
|
—
|
|
||
Common stock, 140,000,000 shares authorized at $0.01 par value, 42,837,741 and 42,616,319 issued and outstanding, as of March 28, 2015 and December 31, 2014, respectively
|
428
|
|
|
426
|
|
||
Additional paid-in capital
|
62,057
|
|
|
62,082
|
|
||
Accumulated deficit
|
(13,937
|
)
|
|
(21,476
|
)
|
||
Accumulated other comprehensive loss
|
(101,136
|
)
|
|
(103,444
|
)
|
||
Total Stockholders’ Deficit
|
(52,588
|
)
|
|
(62,412
|
)
|
||
Total Liabilities and Stockholders’ Deficit
|
$
|
1,281,850
|
|
|
$
|
1,303,880
|
|
|
Three Months Ended
|
||||||
|
March 28, 2015
|
|
March 31, 2014
|
||||
Operating Activities
|
|
|
|
||||
Net income
|
$
|
10,521
|
|
|
$
|
30,947
|
|
Adjustments to reconcile net income to cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
21,752
|
|
|
20,649
|
|
||
Stock-based incentive compensation expense
|
2,669
|
|
|
1,686
|
|
||
Amortization of capitalized debt costs
|
793
|
|
|
—
|
|
||
Deferred income taxes
|
(4,216
|
)
|
|
(804
|
)
|
||
Amortization of losses and prior service costs from pension and postretirement plans
|
3,607
|
|
|
1,308
|
|
||
Loss from sale/disposal of property, plant and equipment
|
382
|
|
|
532
|
|
||
Other
|
80
|
|
|
(161
|
)
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Receivables
|
17,575
|
|
|
(9,011
|
)
|
||
Inventories
|
8,272
|
|
|
3,020
|
|
||
Accounts payable
|
(3,988
|
)
|
|
7,174
|
|
||
Accrued liabilities
|
(3,349
|
)
|
|
2,354
|
|
||
All other operating activities
|
3,091
|
|
|
(2,941
|
)
|
||
Expenditures for disposed operations
|
(1,013
|
)
|
|
—
|
|
||
Cash Provided by Operating Activities
|
56,176
|
|
|
54,753
|
|
||
Investing Activities
|
|
|
|
||||
Capital expenditures
|
(24,540
|
)
|
|
(21,715
|
)
|
||
Other
|
—
|
|
|
508
|
|
||
Cash Used for Investing Activities
|
(24,540
|
)
|
|
(21,207
|
)
|
||
Financing Activities
|
|
|
|
||||
Repayment of debt
|
(20,000
|
)
|
|
—
|
|
||
Proceeds from the issuance of common stock
|
8
|
|
|
—
|
|
||
Net payments to Rayonier
|
—
|
|
|
(33,546
|
)
|
||
Cash Used for Financing Activities
|
(19,992
|
)
|
|
(33,546
|
)
|
||
|
|
|
|
|
|
||
Cash and Cash Equivalents
|
|
|
|
||||
Change in cash and cash equivalents
|
11,644
|
|
|
—
|
|
||
Balance, beginning of year
|
65,977
|
|
|
—
|
|
||
Balance, end of period
|
$
|
77,621
|
|
|
$
|
—
|
|
|
|
|
|
||||
Supplemental Disclosures of Cash Flow Information
|
|
|
|
||||
Cash paid during the period:
|
|
|
|
||||
Interest
|
$
|
1,990
|
|
|
$
|
—
|
|
Income taxes
|
$
|
(307
|
)
|
|
$
|
—
|
|
Non-cash investing and financing activities:
|
|
|
|
||||
Capital assets purchased on account
|
$
|
11,170
|
|
|
$
|
15,390
|
|
|
March 28, 2015
|
|
December 31, 2014
|
||||
Finished goods
|
$
|
112,918
|
|
|
$
|
120,221
|
|
Work-in-progress
|
3,428
|
|
|
2,418
|
|
||
Raw materials
|
13,150
|
|
|
14,670
|
|
||
Manufacturing and maintenance supplies
|
2,441
|
|
|
2,900
|
|
||
Total inventory
|
$
|
131,937
|
|
|
$
|
140,209
|
|
|
March 28, 2015
|
|
December 31, 2014
|
||||
Term A-1 Loan Facility borrowings maturing through 2019 at a variable interest rate of 1.67% (a)
|
$
|
87,736
|
|
|
$
|
106,973
|
|
Term A-2 Loan Facility borrowings maturing through 2021 at a variable interest rate of 1.25% (b)
|
287,146
|
|
|
287,843
|
|
||
Senior Notes due 2024 at a fixed interest rate of 5.50%
|
550,000
|
|
|
550,000
|
|
||
Total debt
|
924,882
|
|
|
944,816
|
|
||
Less: Current maturities of long-term debt
|
(8,207
|
)
|
|
(8,400
|
)
|
||
Long-term debt
|
$
|
916,675
|
|
|
$
|
936,416
|
|
(a)
|
The Term A-1 Loan includes an unamortized issue discount of approximately
$0.2 million
at
March 28, 2015
. Upon maturity the liability will be
$88.0 million
.
|
(b)
|
The Term A-2 Loan includes an unamortized issue discount of approximately
$0.7 million
at
March 28, 2015
. Upon maturity the liability will be
$287.8 million
.
|
Remaining 2015
|
$
|
6,300
|
|
2016
|
8,400
|
|
|
2017
|
9,775
|
|
|
2018
|
11,150
|
|
|
2019
|
66,125
|
|
|
Thereafter
|
824,050
|
|
|
Total principal payments
|
$
|
925,800
|
|
|
March 28, 2015
|
|
December 31, 2014
|
||||||||||||||||||||
|
Carrying
Amount
|
|
Fair Value
|
|
Carrying
Amount
|
|
Fair Value
|
||||||||||||||||
Asset (liability)
|
|
|
Level 1
|
|
Level 2
|
|
|
|
Level 1
|
|
Level 2
|
||||||||||||
Cash and cash equivalents
|
$
|
77,621
|
|
|
$
|
77,621
|
|
|
$
|
—
|
|
|
$
|
65,977
|
|
|
$
|
65,977
|
|
|
$
|
—
|
|
Current maturities of long-term debt
|
(8,207
|
)
|
|
—
|
|
|
(8,400
|
)
|
|
(8,400
|
)
|
|
—
|
|
|
(8,400
|
)
|
||||||
Fixed-rate long-term debt
|
(550,000
|
)
|
|
—
|
|
|
(471,625
|
)
|
|
(550,000
|
)
|
|
—
|
|
|
(453,063
|
)
|
||||||
Variable-rate long-term debt
|
(366,675
|
)
|
|
—
|
|
|
(367,400
|
)
|
|
(386,416
|
)
|
|
—
|
|
|
(387,400
|
)
|
|
March 28, 2015
|
||
Balance, beginning of period
|
$
|
156,729
|
|
Expenditures charged to liabilities
|
(1,013
|
)
|
|
Increase to liabilities
|
15
|
|
|
Balance, end of period
|
155,731
|
|
|
Less: Current portion
|
(8,366
|
)
|
|
Non-current portion
|
$
|
147,365
|
|
|
Three Months Ended
|
||||||
Unrecognized components of employee benefit plans, net of tax
|
March 28, 2015
|
|
March 31, 2014
|
||||
Balance, beginning of period
|
$
|
(103,444
|
)
|
|
$
|
(39,699
|
)
|
Amounts reclassified from accumulated other comprehensive loss (a)
|
2,308
|
|
|
830
|
|
||
Balance, end of period
|
$
|
(101,136
|
)
|
|
$
|
(38,869
|
)
|
(a)
|
These accumulated other comprehensive loss components are included in the computation of net periodic pension cost. See
Note 11
—
Employee Benefit Plans
for additional information.
|
|
Three Months Ended
|
||||||
|
March 28, 2015
|
|
March 31, 2014
|
||||
Net income
|
$
|
10,521
|
|
|
$
|
30,947
|
|
|
|
|
|
||||
Shares used for determining basic earnings per share of common stock
|
42,186,130
|
|
|
42,176,565
|
|
||
Dilutive effect of:
|
|
|
|
||||
Stock options
|
4,948
|
|
|
—
|
|
||
Performance and restricted shares
|
13,696
|
|
|
—
|
|
||
Shares used for determining diluted earnings per share of common stock
|
42,204,774
|
|
|
42,176,565
|
|
||
Basic earnings per share (not in thousands)
|
$
|
0.25
|
|
|
$
|
0.73
|
|
Diluted earnings per share (not in thousands)
|
$
|
0.25
|
|
|
$
|
0.73
|
|
|
Three Months Ended
|
||||
|
March 28, 2015
|
|
March 31, 2014
|
||
Stock options
|
384,112
|
|
|
—
|
|
Restricted stock
|
351,995
|
|
|
—
|
|
Total
|
736,107
|
|
|
—
|
|
|
Three Months Ended
|
||||||
|
March 28, 2015
|
|
March 31, 2014
|
||||
Loss on sale or disposal of property, plant and equipment
|
$
|
382
|
|
|
$
|
532
|
|
One-time separation and legal costs
|
—
|
|
|
2,766
|
|
||
Miscellaneous expense (income)
|
248
|
|
|
(108
|
)
|
||
Total
|
$
|
630
|
|
|
$
|
3,190
|
|
|
Stock Options
|
|
Restricted Stock
|
|
Performance Shares
|
|
Performance-Based Restricted Stock
|
||||||||||||||||||||
|
Options
|
|
Weighted Average Exercise Price
|
|
Awards
|
|
Weighted Average Grant Date Fair Value
|
|
Awards
|
|
Weighted Average Grant Date Fair Value
|
|
Awards
|
|
Weighted Average Grant Date Fair Value
|
||||||||||||
Outstanding at December 31, 2014
|
466,015
|
|
|
$
|
31.73
|
|
|
145,085
|
|
|
$
|
41.66
|
|
|
47,977
|
|
|
$
|
42.27
|
|
|
143,369
|
|
|
$
|
40.52
|
|
Granted
|
—
|
|
|
—
|
|
|
218,371
|
|
|
22.47
|
|
|
214,403
|
|
|
17.51
|
|
|
—
|
|
|
—
|
|
||||
Forfeited
|
(4,580
|
)
|
|
38.31
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Exercised or settled
|
(460
|
)
|
|
17.34
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Expired or cancelled
|
(2,403
|
)
|
|
24.95
|
|
|
—
|
|
|
—
|
|
|
(47,977
|
)
|
|
42.27
|
|
|
—
|
|
|
—
|
|
||||
Outstanding at March 28, 2015
|
458,572
|
|
|
$
|
31.71
|
|
|
363,456
|
|
|
$
|
30.13
|
|
|
214,403
|
|
|
$
|
17.51
|
|
|
143,369
|
|
|
$
|
40.52
|
|
|
Pension
|
Postretirement
|
|||||||||||||
|
Three Months Ended
|
|
Three Months Ended
|
||||||||||||
Components of Net Periodic Benefit Cost
|
March 28, 2015
|
|
March 31, 2014
|
|
March 28, 2015
|
|
March 31, 2014
|
||||||||
Service cost
|
$
|
1,494
|
|
|
$
|
553
|
|
|
$
|
205
|
|
|
$
|
157
|
|
Interest cost
|
3,807
|
|
|
1,949
|
|
|
231
|
|
|
153
|
|
||||
Expected return on plan assets
|
(5,809
|
)
|
|
(3,314
|
)
|
|
—
|
|
|
—
|
|
||||
Amortization of prior service cost
|
188
|
|
|
292
|
|
|
4
|
|
|
4
|
|
||||
Amortization of losses
|
3,358
|
|
|
1,023
|
|
|
127
|
|
|
123
|
|
||||
Amortization of negative plan amendment
|
—
|
|
|
—
|
|
|
(70
|
)
|
|
(134
|
)
|
||||
Total net periodic benefit cost
|
$
|
3,038
|
|
|
$
|
503
|
|
|
$
|
497
|
|
|
$
|
303
|
|
|
|
|
|
|
|
|
|
Financial Commitments
|
Maximum Potential Payment
|
||
Standby letters of credit (a)
|
$
|
27,889
|
|
Surety bonds (b)
|
55,652
|
|
|
Total financial commitments
|
$
|
83,541
|
|
(a)
|
The letters of credit primarily provide credit support for surety bonds issued to comply with financial assurance requirements relating to environmental remediation of disposed sites. The letters of credit will expire during 2015 and will be renewed as required.
|
(b)
|
Rayonier Advanced Materials purchases surety bonds primarily to comply with financial assurance requirements relating to environmental remediation and post closure care and to provide collateral for the Company’s workers’ compensation program. These surety bonds expire at various dates during 2015 and 2019. They are expected to be renewed annually as required.
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Three Months Ended
|
||||||
Financial Information (in millions)
|
March 28, 2015
|
|
March 31, 2014
|
||||
Net Sales
|
|
|
|
||||
Cellulose specialties
|
$
|
179
|
|
|
$
|
206
|
|
Commodity products and other
|
42
|
|
|
37
|
|
||
Total Net Sales
|
221
|
|
|
243
|
|
||
|
|
|
|
||||
Cost of Sales
|
184
|
|
|
189
|
|
||
Gross Margin
|
37
|
|
|
54
|
|
||
Selling and general expenses
|
12
|
|
|
8
|
|
||
Other operating expense, net
|
1
|
|
|
3
|
|
||
Operating Income
|
24
|
|
|
43
|
|
||
Interest, net
|
9
|
|
|
—
|
|
||
Income Before Income Taxes
|
15
|
|
|
43
|
|
||
Income Tax Expense
|
4
|
|
|
12
|
|
||
Net Income
|
$
|
11
|
|
|
$
|
31
|
|
|
|
|
|
||||
Other Data
|
|
|
|
||||
Sales Prices ($ per metric ton)
|
|
|
|
||||
Cellulose specialties
|
$
|
1,667
|
|
|
$
|
1,823
|
|
Commodity products
|
686
|
|
|
689
|
|
||
Sales Volumes (thousands of metric tons)
|
|
|
|
||||
Cellulose specialties
|
107
|
|
|
113
|
|
||
Commodity products
|
58
|
|
|
50
|
|
||
|
|
|
|
||||
Gross Margin %
|
16.7
|
%
|
|
22.2
|
%
|
||
Operating Margin %
|
10.9
|
%
|
|
17.7
|
%
|
||
Effective Tax Rate %
|
28.2
|
%
|
|
28.6
|
%
|
Sales (in millions)
|
March 31, 2014
|
|
Changes Attributable to:
|
|
March 28, 2015
|
||||||||||
Three Months Ended
|
Price
|
|
Volume/Mix
|
|
|||||||||||
Cellulose specialties
|
$
|
206
|
|
|
$
|
(17
|
)
|
|
$
|
(10
|
)
|
|
$
|
179
|
|
Commodity products and other
|
37
|
|
|
—
|
|
|
5
|
|
|
42
|
|
||||
Total Sales
|
$
|
243
|
|
|
$
|
(17
|
)
|
|
$
|
(5
|
)
|
|
$
|
221
|
|
|
|
|
|
|
|
|
|
Operating Income (in millions)
|
March 31, 2014
|
|
Changes Attributable to (a):
|
|
March 28, 2015
|
||||||||||||||
Three Months Ended
|
Price
|
|
Volume / Sales Mix
|
|
Cost
|
|
|||||||||||||
Operating Income
|
$
|
43
|
|
|
$
|
(17
|
)
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
24
|
|
Operating Margin %
|
17.7
|
%
|
|
(6.2
|
)%
|
|
0.3
|
%
|
|
(0.9
|
)%
|
|
10.9
|
%
|
(a)
|
Computed based on contribution margin.
|
|
|
|
|
|
|
|
|
|
|
|
March 28, 2015
|
|
December 31, 2014
|
||||
Cash and cash equivalents (a)
|
$
|
78
|
|
|
$
|
66
|
|
Availability under the Revolving Credit Facility (b)
|
222
|
|
|
222
|
|
||
Total debt (c)
|
925
|
|
|
945
|
|
||
Stockholders’ deficit
|
(53
|
)
|
|
(62
|
)
|
||
Total capitalization (total debt plus equity)
|
872
|
|
|
883
|
|
||
Debt to capital ratio
|
106
|
%
|
|
107
|
%
|
(a)
|
Cash and cash equivalents consisted of cash, money market deposits, and time deposits with original maturities of 90 days or less.
|
(b)
|
Availability under the revolving credit facility is reduced by stand-by letters of credit of approximately $28 million.
|
(c)
|
See
Note 3
—
Debt
for additional information.
|
Cash provided by (used for):
|
March 28, 2015
|
|
March 31, 2014
|
||||
Operating activities
|
$
|
56
|
|
|
$
|
55
|
|
Investing activities
|
(24
|
)
|
|
(21
|
)
|
||
Financing activities
|
(20
|
)
|
|
(34
|
)
|
|
Three Months Ended
|
||||||
Net Income to EBITDA Reconciliation
|
March 28, 2015
|
|
March 31, 2014
|
||||
Net Income
|
$
|
11
|
|
|
$
|
31
|
|
Interest, net
|
9
|
|
|
—
|
|
||
Income tax expense
|
4
|
|
|
12
|
|
||
Depreciation and amortization
|
22
|
|
|
21
|
|
||
EBITDA
|
46
|
|
|
64
|
|
||
One-time separation and legal costs
|
—
|
|
|
3
|
|
||
Pro Forma EBITDA
|
46
|
|
|
67
|
|
Cash used for investing activities
|
$
|
(24
|
)
|
|
$
|
(21
|
)
|
Cash used for financing activities
|
$
|
(20
|
)
|
|
$
|
(34
|
)
|
(a)
|
Capital expenditures exclude strategic capital expenditures which are deemed discretionary by management. Strategic capital totaled $0 million for the
three
months ended
March 28, 2015
. Strategic capital totaled
$1 million
for a land purchase near the Jesup plant for the
three
months ended
March 31, 2014
.
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Item 4.
|
Controls and Procedures
|
Part II.
|
Other Information
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Period
|
Total Number of Shares Purchased (a)
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
|
|||||
January 1 to January 31
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
February 1 to February 28
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
March 1 to March 28
|
569
|
|
|
$
|
19.00
|
|
|
—
|
|
|
—
|
|
Total
|
569
|
|
|
|
|
—
|
|
|
|
(a)
|
Repurchased to satisfy the minimum tax withholding requirements related to the vesting of restricted stock under the Rayonier Advanced Materials Incentive Stock Plan.
|
Item 6.
|
Exhibits
|
10.1
|
Rayonier Advanced Materials Inc. Incentive Stock Plan, as amended effective January 1, 2016*
|
|
Filed herewith
|
10.2
|
Amendment dated March 23, 2015 to Agreement between Rayonier Advanced Materials Inc. and Paul G. Boynton Regarding Retention Award*
|
|
Filed herewith
|
10.3
|
Rayonier Advanced Materials Inc. Executive Severance Pay Plan, as amended effective January 1, 2016*
|
|
Filed herewith
|
31.1
|
Chief Executive Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
31.2
|
Chief Financial Officer’s Certification Pursuant to Rule 13a-14(a)/15d-14(a) and pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith
|
32
|
Certification of Periodic Financial Reports Under Section 906 of the Sarbanes-Oxley Act of 2002
|
|
Furnished herewith
|
101
|
The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2015, formatted in Extensible Business Reporting Language (“XBRL”), includes: (i) the Condensed Consolidated Statements of Income and Comprehensive Income for the Three Months Ended March 28, 2015 and March 31, 2014; (ii) the Condensed Consolidated Balance Sheets as of March 28, 2015 and December 31, 2014; (iii) the Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 28, 2015 and March 31, 2014; and (iv) the Notes to Condensed Consolidated Financial Statements
|
|
Filed herewith
|
|
|
Rayonier Advanced Materials Inc.
|
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/ F
RANK
A. R
UPERTO
|
|
|
Frank A. Ruperto
Chief Financial Officer and
Senior Vice President, Finance and Strategy
(Duly Authorized Officer and Principal Financial Officer)
|
1.
|
Purpose
|
2.
|
Definitions
|
3.
|
Shares Subject to the Plan
|
4.
|
Grant of Awards and Award Agreements
|
5.
|
Stock Options and Rights
|
6.
|
Performance Shares
|
7.
|
Restricted Stock and Restricted Stock Units
|
8.
|
Certificates for Awards of Stock
|
9.
|
Change in Control Events Occurring on or before December 31, 2015
|
(i)
|
subject to the conditions contained in the final paragraph of this definition, the filing of a report on Schedule 13D with the Securities and Exchange Commission pursuant to Section 13(d) of the Act disclosing that any person, other than the Company or any employee benefit plan sponsored by the Company, is the beneficial owner (as the term is defined in Rule 13d-3 under the Act) directly or indirectly, of securities representing 20 percent or more of the total voting power represented by the Company’s then outstanding Voting Securities (calculated as provided in paragraph (d) of Rule 13d-3 under the Act in the case of rights to acquire Voting Securities); or
|
(ii)
|
the purchase by any person, other than the Company or any employee benefit plan sponsored by the Company, of shares pursuant to a tender offer or exchange offer to acquire any Voting Securities of the Company (or securities convertible into such Voting Securities) for cash, securities, or any other consideration, provided that after consummation of the offer, the person in question is the beneficial owner, directly or indirectly, of securities representing 20 percent or more of the total voting power represented by the Company’s then outstanding Voting Securities (all as calculated under clause (i)); or
|
(iii)
|
the approval by the shareholders of the Company, and the subsequent occurrence, of (A) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation (other than a merger of the Company in which holders of Common Shares of the Company immediately prior to the merger have the
|
(iv)
|
a change in the composition of the Board of the Company at any time during any consecutive 24-month period such that “continuing directors” cease for any reason to constitute at least a 70 percent majority of the Board.
|
9A.
|
Change in Control Events Occurring on or After January 1, 2016
|
(i)
|
subject to the conditions contained in the final paragraph of this definition, the filing of a report on Schedule 13D with the Securities and Exchange Commission pursuant to Section 13(d) of the Act disclosing that any person, other than the Company or any employee benefit plan sponsored by the Company, is the beneficial owner (as the term is defined in Rule 13d-3 under the Act) directly or indirectly, of securities representing twenty percent (20%) or more of the total voting power represented by the Company’s then outstanding Voting Securities (calculated as provided in paragraph (d) of Rule 13d-3 under the Act in the case of rights to acquire Voting Securities); or
|
(ii)
|
the purchase by any person, other than the Company or any employee benefit plan sponsored by the Company, of shares pursuant to a tender offer or exchange offer to acquire any Voting Securities of the Company (or securities convertible into such Voting Securities) for cash, securities, or any other consideration, provided that after consummation of the offer, the person in question is the beneficial owner, directly or indirectly, of securities representing twenty percent (20%) or more of the total voting power represented by the Company’s then outstanding Voting Securities (all as calculated under clause (i)); or
|
(iii)
|
the approval by the shareholders of the Company, and the subsequent occurrence, of (A) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation (other than a merger of the Company in which holders of Common Shares of the Company immediately prior to the merger have the same proportionate ownership of Common Shares of the surviving corporation immediately after the merger as immediately before), or pursuant to which Common Shares of the Company would be converted into cash, securities, or other property, or (B) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all or substantially all the assets of the Company; or
|
(iv)
|
a change in the composition of the Board of the Company at any time during any consecutive 24-month period such that “continuing directors” cease for any reason to constitute at least a 70 percent majority of the Board.
|
10.
|
Beneficiary
|
11.
|
Administration of the Plan
|
12.
|
Amendment, Extension or Termination
|
13.
|
Adjustments in Event of Change in Common Stock and Change in Control
|
15.
|
Conditions Subsequent
|
16.
|
Miscellaneous
|
17.
|
Effective Date, Term of Plan and Shareholder Approval
|
|
|
|
|
|
|
By:
|
|
|
Name:
|
|
Jay Posze
|
Title:
|
|
SVP, Human Resources
|
|
|
Rayonier Advanced Materials Inc.
|
ACCEPTED AND AGREED:
|
|
|
Paul Boynton
|
Date:
|
|
|
|
|
|
|
A.
|
Qualifying Termination
. If, within two years following a Change in Control, (a) an Executive terminates his or her full time employment for Good Reason, or (b) the Company terminates an Executive’s full time employment, the Executive shall be provided Scheduled Severance Pay and Additional Severance (collectively, “
Separation Benefits
”) in accordance with the terms of this Plan, except that Separation Benefits shall not be payable where Executive:
|
•
|
is terminated for Cause;
|
•
|
voluntarily resigns (including normal retirement), other than for Good Reason;
|
•
|
voluntarily fails to return from an approved leave of absence (including a medical leave of absence); or
|
•
|
terminates employment as a result of Executive’s death or Disability.
|
B.
|
Definitions Related to Qualifying Termination
. For purposes of this Section 3, the following terms have the indicated definitions:
|
90965725.4
|
3
|
|
A.
|
An Executive’s “
Scheduled Severance Pay
” is the product of the Executive’s Base Pay times the Executive’s Applicable Tier Multiplier.
|
90965725.4
|
4
|
|
B.
|
An Executive’s “
Additional Severance
” is the sum of the Executive’s Benefits Continuation Amount, calculated as provided in
Section 4C
below, and the Executive’s Bonus Severance, calculated as provided in this
Section 4B
.
|
(i)
|
An Executive’s “
Bonus Severance
” is the product of the Executive’s Applicable Bonus times the Executive’s Applicable Tier Multiplier, together with an additional amount equal to the Executive’s Current Pro-rata Bonus.
|
(1)
|
An Executive’s “
Applicable Bonus
” is the greatest of (A) the highest bonus amount actually paid to the Executive under the Rayonier Advanced Materials annual incentive bonus plan (the “
Bonus Plan
”) in the three year period comprised of the year of the Qualifying Termination and the two immediately preceding calendar years, (B) the Executive’s Target Bonus Award under the Bonus Plan for the year in which the Change in Control takes place or (C) the Executive’s Target Bonus Award under the Bonus Plan in the year of Qualifying Termination. The Executive’s Applicable Bonus shall be determined without regard to any election the Executive may have made to defer receipt of all or any portion thereof as if there had been no deferral election in effect.
|
(2)
|
An Executive’s “
Current Pro-rata Bonus
” is equal to the product of the Executive’s Applicable Bonus times a fraction the numerator of which is the number of months or portion thereof lapsed in the then current year prior to the Qualifying Termination and the denominator of which is twelve.
|
C.
|
Benefits Continuation Amounts
. The Executive’s Benefits Continuation Amount is the sum of the Executive’s Retirement Savings Adjustment and Other Benefits Adjustment. The Executive’s Retirement Savings Adjustment shall be in addition to amounts to which Executive is entitled under the Retirement Plan for Salaried Employees of Rayonier Advanced Materials Inc., the Retirement Plan for Salaried Employees of ITT Corporation, the Rayonier Advanced Materials Investment and Savings Plan for Salaried Employees and the Supplemental Plans (collectively, the “
Retirement Plans
”), in effect on the Effective Date of the Qualifying Termination. (Capitalized terms in this
Section 4C
that are not otherwise defined here or elsewhere in this Plan shall have the meaning ascribed to them in the applicable Retirement Plans.)
|
(i)
|
An Executive’s “
Retirement Savings Adjustment
” is an amount equal to the excess of (X) over (Y), where (X) is the “
Equivalent Actuarial Value
” of the benefit to which Executive would have been entitled under the terms of the Retirement Plans, without regard to “vesting” thereunder, had Executive accumulated an additional 3 years of eligibility service as a fully vested participant in the Retirement Plans and an additional 3 years of benefit service in all the Retirement Plans other than the Retirement Plan for Salaried Employees of ITT Corporation and the ITT Supplemental Plans and as if Executive were 3 years older, solely for purposes of benefit eligibility and determining the amount of reduction in benefit on account of payment commencing prior to the Executive’s normal retirement date, and by
|
90965725.4
|
5
|
|
(ii)
|
Other Benefits Adjustment
. The “
Other Benefits Adjustment
” is an amount equal to the sum of the Medical Benefits Payment, the Executive Tax Services Payment and the Outplacement Services, determined as provided in subsections (1) - (3) below.
|
(1)
|
An Executive’s “
Medical Benefits Payment
” is the product of the employer contribution component of the health and welfare plans maintained for the Executive as of the Change in Control under the applicable employee welfare benefit plan (within the meaning of Section 3(1) of ERISA) maintained by the Company for the benefit of the Company’s employees at such date, times the Executive’s Applicable Tier Multiplier, discounted for present value applying a 4% discount rate.
|
(2)
|
An Executive’s “
Executive Tax Services Payment
” means $10,000 in the case of a Tier II Executive and, in the case of a Tier I Executive, the amount that otherwise would be payable for one year under the Company’s Senior Executive Tax Plan (or any successor thereto), as applicable to the Executive immediately prior to the Change in Control, together with an amount equal to any Senior Executive Tax Plan benefits accrued but unpaid as of the Effective Date of the Qualifying Termination.
|
90965725.4
|
6
|
|
(3)
|
“
Outplacement Services
” means the cost of outplacement services, the scope and provider of which shall be selected by Executive in his or her sole discretion, for a period not to extend beyond twelve (12) months after the Effective Date of Executive’s Qualifying Termination, in an amount not to exceed $30,000 in the aggregate.
|
D.
|
Equity Benefits
. Company shall provide to Executive the following additional benefits upon a Qualifying Termination of the Executive, to the extent not actually provided under an Applicable Incentive Stock Plan of the Company (collectively, the “
Equity Benefits
”). Terms used in this
Section 4D
not otherwise defined in this Plan shall have the meaning assigned in the Applicable Incentive Stock Plan.
|
(i)
|
Options
. The Company shall cause all of the options to purchase the Common Shares of the Company (“
Stock Options
”) granted to Executive prior to the Qualifying Termination by the Company to become immediately exercisable in full in accordance with the terms of the Applicable Incentive Stock Plan pursuant to which they were issued (provided that no Stock Option shall be exercisable after the termination date of such Stock Option).
|
(ii)
|
Restricted Stock
. The Company shall (a) cause Executive to immediately vest in all outstanding shares of Restricted Stock that were the subject of an Award under the Applicable Incentive Stock Plan, which Restricted Stock is held by or for the benefit of the Executive immediately prior to the Qualifying Termination without any remaining restrictions other than those imposed by applicable securities laws, and (b) issue stock certificates in respect thereof to Executive without a restrictive legend.
|
(iii)
|
Restricted Stock Units
. The Company shall cause all unvested Restricted Stock Units granted to Executive prior to the Qualifying Termination by the Company to become immediately vested and to be settled in accordance with the terms of the Applicable Incentive Stock Plan.
|
(iv)
|
Performance Share Awards
. In the event of a Qualifying Termination, Awards of “
Performance Shares
” under all “
Performance Share Award Programs
” shall be settled as follows: (a) with respect to any Award for which the applicable Performance Period is more than 50% completed, the Performance Period shall be deemed to end as of the date of the Qualifying Termination and the Executive shall receive the greater of (1) the result obtained by applying the share price at the closing of the transaction causing the Change in Control for purposes of measuring Company performance with that of the comparison group at that time under the applicable program, and (2) the Award at 100% of target performance under the applicable program; and (b) with respect to any Award as to which the applicable Performance Period is not more than 50% completed, the Executive shall receive the Award at 100% of target performance under the applicable program.
|
90965725.4
|
7
|
|
(v)
|
Coordination with Incentive Stock Plans
. Any amounts paid or payable hereunder shall be an offset against amounts otherwise due from the Company under the Applicable Incentive Stock Plan in respect of the same Award covered herein.
|
(vi)
|
Coordination with Section 409A
. If at any time the payment of an Equity Benefit would be deemed to be payable to an Executive as a result of the Executive’s Separation from Service, payment of such Equity Benefit shall not be made earlier than the end of the Separation Delay Period where on the date of the Separation from Service the Executive was a Specified Employee; provided that, such delay in payment shall not apply to any portion of the Equity Benefit that is excepted from such delay under the Code Section 409A Rules as a Short-Term Deferral, Separation Pay or otherwise. It is the intention that all payments under this Plan be excluded from penalties under the Code Section 409A Rules.
|
A.
|
In the event any dispute arises between Executive and the Company as to the validity, enforceability and/or interpretation of any right or benefit afforded by this Plan, at Executive’s option such dispute shall be resolved by binding arbitration proceedings in accordance with the rules of the American Arbitration Association. The arbitrators shall presume that the rights and/or benefits afforded by this Plan which are in dispute are valid and enforceable and that Executive is entitled to such rights and/or benefits. The Company shall be precluded from asserting that such rights and/or benefits are not valid, binding and enforceable and shall stipulate before such arbitrators that the Company is bound by all the provisions of this Plan. The burden of overcoming by clear and convincing evidence the presumption that Executive is entitled to such rights and/or benefits shall be on the Company. The results of any arbitration shall be conclusive on both parties and shall not be subject to judicial interference or review on any ground whatsoever, including without limitation any claim that the Company was wrongfully induced to enter into this agreement to arbitrate such a dispute.
|
B.
|
In the event Executive is required to defend in any legal action or other proceeding the validity or enforceability of any right or benefit afforded by this Plan, the Company will pay any and all actual legal fees and expenses incurred by such Executive regardless of the outcome of such action and, if requested by Executive, shall (within two business days of such request) advance such expenses to Executive. The Company shall be precluded from asserting in any judicial or other proceeding commenced with respect to any right or benefit afforded by this Plan that such rights and benefits are not valid, binding and enforceable
|
90965725.4
|
8
|
|
C.
|
Amounts payable by the Company under this
Section 5
shall in the first instance be paid by the trustee under the trust established by that certain Trust Agreement, known as the “
Legal Resources Trust
”, to the extent such amounts were previously transferred by the Company to the trustee of the Legal Resources Trust.
|
A.
|
As a condition to the receipt of a designated portion of the Plan Benefits otherwise payable hereunder in cash (such portion, the “
Covenant Amount
”) and in consideration thereof, Executive shall be deemed to have made and be bound by the “
Change in Control Covenants
” (defined below), which at the request of the Company shall be acknowledged by Executive in a simple declarative statement “I hereby confirm that I am bound by the Change in Control Covenants” attested to in writing by the Executive. The Covenant Amount shall be equal to so much of the identified amount payable in cash as the Company shall designate in a written notice to Executive given within thirty (30) days of the Qualifying Termination; provided that, the Covenant Amount shall not exceed an amount equal to the Base Pay of Executive immediately before the Qualifying Termination multiplied by the Executive’s Applicable Tier Multiplier and determined by the Company in good faith to be reasonable compensation for the Change in Control Covenants. For the sake of clarity, the Covenant Amount shall not be an additional payment beyond the Plan Benefits provided for under this Plan; rather, a portion of the Plan Benefits that the Executive is otherwise entitled to receive hereunder shall be allocated as the Covenant Amount; and provided further that, an Executive who receives any Plan Benefit under this Plan shall make, and will be bound by, the Change in Control Covenants.
|
B.
|
The Executive’s “
Change in Control Covenants
” are the Non-compete Covenants and the Confidentiality Covenants as set forth in this
Section 6B
.
|
(vii)
|
Non-compete Covenants
. For a period equal to one year following a Qualifying Termination (the “
Covenant Period
”), Executive covenants that Executive shall not, without the prior authorization of the Company (which shall not be unreasonably withheld):
|
(1)
|
accept or maintain employment with, or act as a principal of, or advisor or consultant to, or otherwise act as an agent of, any person, firm, corporation or other entity that competes directly with Company immediately before the Qualifying Termination; or
|
(2)
|
solicit any client having a relationship with the Company to terminate or reduce in a way materially adverse to the Company any relationship such client has with the Company; or
|
90965725.4
|
9
|
|
(3)
|
solicit for employment any individual that was employed by the Company within sixty (60) days preceding the Qualifying Termination and who was employed by the Company during the Covenant Period and within sixty (60) days prior to such solicitation; or
|
(4)
|
except as permitted or compelled by law, orally or in writing, disparage, demean or deprecate the Company or any products of the Company.
|
(viii)
|
Confidentiality Covenants
. While employed by the Company following the Change in Control, and for a period of two (2) years following a Qualifying Termination (the “
Confidential Information Period
”), Executive covenants that Executive shall not disclose or make available to any person or entity any “Confidential Information” (as defined below) and shall not use or cause to be used any Confidential Information for any purpose other than fulfilling Executive’s employment obligations to the Company, without the express prior written authorization of the Company. For this purpose, “
Confidential Information
” means all information about the Company relating to any of its products or services or any phase of operations, including, without limitation, business plans and strategies, trade secrets, know-how, contracts, financial statements, pricing strategies, costs, customers and potential customers, vendors and potential vendors, marketing and distribution information, business results, software, hardware, databases, processes, procedures, technologies, designs, concepts, ideas, and methods not generally known through legitimate means to any of its competitors with which Executive became acquainted during the term of employment by the Company.
|
(ix)
|
Certain Public Company Employment
. Executive will not be considered to have violated the covenant in Section 6B(i)(1) above by employment with a public company that competes with the Company as long as no competing division of the public company reports to Employee.
|
C.
|
Remedies Limited to Equitable Relief
. By accepting payment of the Covenant Amount, Executive shall be deemed (a) to have acknowledged that in the event Executive breaches any of the Change in Control Covenants, the damages to the Company would be irreparable and that the Company shall have the right to seek injunctive and/or other equitable relief in any court of competent jurisdiction to enforce the Change in Control Covenants and (b) to have consented to the issuance of a temporary restraining order to maintain the status quo pending the outcome of any proceeding. The foregoing shall be the exclusive remedy of the Company for a breach of the Change in Control Covenants and under no circumstances
|
90965725.4
|
10
|
|
A.
|
Notwithstanding any provision of this Plan to the contrary, in the event that the payments and other benefits payable under this Plan or otherwise payable to the Executive under any other plan, program, arrangement, or agreement maintained by the Company or one of its affiliates (i) would constitute an “excess parachute payment” (as defined under Code Section 280G ) and (ii) would be subject to the excise tax imposed by Section 4999 of the Code, then such payments and other benefits shall be payable either (x) in full or (y) in a reduced amount that would result in no portion of such payments and other benefits being subject to the excise tax imposed under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state, and local income taxes and the excise tax imposed by Section 4999 of the Code, results in the receipt by such Executive on an after-tax basis, of the greatest amount of severance benefits under this Plan or otherwise, notwithstanding that all or some portion of such severance benefits may be taxable under Section 4999 of the Code.
|
B.
|
The determination of whether it is necessary to decrease a payment or benefit to be paid under this Plan must be made in good faith by a nationally recognized certified public accounting firm (the “
Accounting Firm
”) selected by the Company. This determination will be conclusive and binding upon the Executive and the Company. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity, or group effecting the Change in Control, the Company shall appoint another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). The Company shall bear all fees of the Accounting Firm. If a reduction is necessary, the Executive will have the right to designate the particular payment or benefit to be reduced or eliminated so that no portion of the payment or benefit to be paid to the Executive will be an excess parachute payment subject to the deduction limits under Section 280G of the Code and the excise tax under Section 4999. However, no payment of “deferred compensation” (as defined under Treasury Regulation Section 1.409-1(b)(1) after giving effect to the exemptions in Treasury Regulation Sections 1.409-1(b)(3) through (b)(12)) may be reduced to the extent that a reduction can be made to any payment or benefit that is not “deferred compensation.”
|
90965725.4
|
11
|
|
90965725.4
|
12
|
|
90965725.4
|
13
|
|
90965725.4
|
14
|
|
90965725.4
|
15
|
|
90965725.4
|
16
|
|
90965725.4
|
17
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Rayonier Advanced Materials Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
/s/ P
AUL
G. B
OYNTON
|
|
Paul G. Boynton
Chairman, President and Chief Executive Officer
|
|
Rayonier Advanced Materials Inc.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Rayonier Advanced Materials Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
/s/ F
RANK
A. R
UPERTO
|
|
Frank A. Ruperto
Chief Financial Officer and
Senior Vice President, Finance and Strategy
|
|
Rayonier Advanced Materials Inc.
|
1.
|
The quarterly report on Form 10-Q of Rayonier Advanced Materials Inc. (the "Company") for the period ended
March 28, 2015
(the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ P
AUL
G. B
OYNTON
|
|
/s/ F
RANK
A. R
UPERTO
|
Paul G. Boynton
|
|
Frank A. Ruperto
|
Chairman, President and Chief Executive Officer
|
|
Chief Financial Officer and
Senior Vice President, Finance and Strategy
|
Rayonier Advanced Materials Inc.
|
|
Rayonier Advanced Materials Inc.
|